Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT00003274
First received: November 1, 1999
Last updated: May 20, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2002
  Primary Completion Date: September 2001 (Final data collection date for primary outcome measure)